Children, 6–23 months | Children, 24–59 months | Children, 6–59 months | ||||||||
Mean Hb (g/L), Survey Median (IQR) | Prevalence of total anaemia*, Survey Median (IQR) | Prevalence of moderate+severe anaemia†, Survey Median (IQR) | Mean Hb (g/L), Survey Median (IQR) | Prevalence of total anaemia*, Survey Median (IQR) | Prevalence of moderate+severe anaemia†, Survey Median (IQR) | Mean Hb (g/L), Survey Median (IQR) | Prevalence of total anaemia*, Survey Median (IQR) | Prevalence of moderate +severe anaemia†, Survey Median (IQR) | Per cent of surveys with severe public health problem‡ | |
By survey | ||||||||||
Total | 107 (103–109) | 56.1 (48.3–67.1) | 27.7 (19.7–37.7) | 113 (110–115) | 36.1 (26.6–46.0) | 14.2 (9.1–20.0) | 111 (108–113) | 43.9 (34.0–52.3) | 19.1 (13.2–25.4) | 61.2 |
Region | ||||||||||
Eastern and Southern Africa | 107 (104–109) | 55.5 (48.9–63.0) | 27.4 (20.6–32.7) | 113 (111–116) | 36.4 (25.7–43.8) | 13.1 (8.2–18.6) | 111 (109–113) | 44.0 (35.6–48.1) | 18.7 (14.5–22.3) | 64.1 |
Ethiopia | 105 (102–109) | 60.1 (46.7–69.1) | 31.7 (19.6–38.8) | 113 (111–118) | 34.4 (23.7–41.7) | 14.1 (7.8–17.7) | 110 (108–115) | 43.9 (32.0–51.2) | 19.9 (13.3–23.9) | 56.0 |
West and Central Africa | 101 (98–105) | 71.4 (60.3–76.3) | 42.7 (32.2–48.2) | 107 (103–110) | 52.2 (45.5–62.1) | 27.2 (22.4–37.7) | 106 (101–108) | 58.0 (50.5–67.9) | 32.4 (26.0–41.8) | 96.4 |
Chad | 108 (106–110) | 50.3 (46.5–57.6) | 21.0 (17.0–27.3) | 114 (111–115) | 32.0 (28.1–37.2) | 12.7 (9.7–17.3) | 112 (110–114) | 38.6 (33.3–45.2) | 15.0 (12.2–20.8) | 42.1 |
Middle East and North Africa | 107 (105–111) | 56.0 (44.4–63.5) | 22.8 (17.0–29.0) | 113 (112–115) | 36.0 (31.6–39.3) | 11.9 (8.7–15.9) | 111 (110–113) | 43.1 (34.5–44.9) | 16.1 (11.9–19.3) | 66.7 |
South Asia | 112 (110–112) | 43.1 (38.4–47.0) | 7.6 (5.7–16.8) | 120 (118–120) | 13.4 (10.9–14.9) | 1.3 (0.4–2.6) | 117 (115–117) | 22.6 (21.4–26.6) | 3.5 (2.2–8.5) | 0.0 |
Year | ||||||||||
2013 | 106 (102–109) | 55.5 (47.6–68.0) | 27.0 (18.7–38.5) | 113 (111–117) | 33.9 (22.9–43.3) | 12.6 (7.6–18.8) | 111 (108–114) | 43.2 (32.1–51.2) | 17.0 (12.6–23.4) | 51.9 |
2014 | 105 (103–108) | 57.9 (52.4–68.6) | 30.0 (24.4–37.8) | 112 (109–115) | 36.4 (28.1–46.0) | 15.1 (10.8–24.6) | 110 (107–112) | 44.6 (36.4–51.9) | 20.3 (17.3–27.7) | 72.2 |
2015 | 108 (104–109) | 52.7 (46.6–64.4) | 24.1 (18.1–35.6) | 113 (109–116) | 37.0 (27.0–47.4) | 15.5 (9.5–19.6) | 111 (108–113) | 43.4 (33.5–51.2) | 17.8 (13.3–25.3) | 60.0 |
2016 | 106 (102–110) | 59.6 (48.7–67.3) | 27.4 (16.2–37.3) | 113 (110–116) | 34.3 (25.6–46.7) | 13.2 (8.4–23.4) | 111 (107–114) | 42.4 (34.8–54.3) | 18.0 (11.5–26.9) | 60.0 |
By setting§ | ||||||||||
Total | 107 (103–109) | 56.6 (48.0–65.7) | 28.0 (20.4–36.5) | 112 (110–116) | 37.3 (26.4–46.7) | 15.1 (8.8–22.0) | 110 (107–113) | 44.6 (34.1–52.8) | 19.0 (13.1–25.8) | 61.4 |
Region | ||||||||||
Eastern and Southern Africa | 107 (104–109) | 56.0 (48.2–62.7) | 28.0 (21.3–31.4) | 113 (110–116) | 36.3 (25.8–43.3) | 13.8 (8.4–19.1) | 111 (109–113) | 43.9 (35.9–49.6) | 18.6 (15.3–23.6) | 63.4 |
Ethiopia | 107 (103–110) | 55.9 (46.0–66.0) | 28.0 (18.4–38.1) | 116 (111–121) | 29.0 (21.6–39.7) | 13.2 (5.3–16.4) | 113 (109–117) | 37.5 (30.9–48.6) | 18.8 (10.7–23.2) | 47.6 |
West and Central Africa | 102 (99–105) | 67.0 (60.5–74.9) | 38.9 (33.6–46.2) | 108 (104–110) | 50.5 (43.8–61.5) | 27.3 (21.3–35.1) | 106 (102–108) | 57.1 (49.4–65.6) | 31.7 (25.0–39.4) | 95.0 |
Chad | 107 (106–109) | 52.0 (46.7–58.1) | 23.6 (17.4–27.7) | 114 (110–115) | 32.3 (29.2–45.5) | 14.0 (10.3–20.7) | 112 (109–113) | 39.1 (34.4–48.7) | 16.6 (12.9–21.9) | 47.4 |
Middle East and North Africa | 107 (105–112) | 54.3 (41.2–60.8) | 22.4 (15.3–28.2) | 113 (112–115) | 35.8 (31.7–38.7) | 12.6 (7.5–15.9) | 111 (110–112) | 43.2 (37.1–45.0) | 16.6 (12.7–20.8) | 60.0 |
South Asia | 112 (110–113) | 42.9 (34.0–47.0) | 6.1 (5.3–16.8) | 119 (119–120) | 13.0 (11.4–16.0) | 0.5 (0.3–2.6) | 117 (115–117) | 23.3 (21.9–25.5) | 2.5 (1.9–8.5) | 0.0 |
*Total anaemia defined as Hb <110 g/L.
†Moderate+severe anaemia defined as Hb <100 g/L.
‡Severe public health problem defined as prevalence of total anaemia ≥40%.
§Median value for each indicator across all surveys conducted in a given setting (refugee camp or non-camp site).
Hb, haemoglobin; UNCHR, United Nations High Commissioner for Refugees.